Albany Molecular Research, Inc. announced that it has
established a wholly owned subsidiary, Albany Molecular Research Singapore
Research Centre, Pte Ltd (AMRSRC). AMRI expects to initiate operations in
Singapore in the first quarter of 2005, with the goal of providing a full
range of fee-for-service chemistry technologies, including medicinal and
combinatorial chemistry, process research and scale up chemistry,
analytical services and cGMP manufacture of active pharmaceutical
AMRI's Singapore operations will be overseen by Senior Vice
President, Chemistry, Michael P. Trova, Ph.D., and led in Singapore by
Assistant Director, Medicinal Chemistry Polivina Jolicia F. Gauuan, Ph.D.
Three additional scientists from Albany will be relocating to Singapore to
form the nucleus of AMRSRC, and they are actively recruiting in Singapore
with the expectation of hiring new scientists locally in the coming months.